Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 17 Next »

            

Working Groups – Q4 2024 Summary 

Welcome to the PHUSE Quarter 4 2024 Working Group Report Summary, which includes a 2024 year-end analysis.

Q4 has been a busy quarter, with many new deliverables started, 5 published across the Working Groups, including 3 white papers, FAQs and a blog. Working Groups have also seen 6 new projects opening their doors to volunteers and even more Working Group events!

Working Groups have been extremely active across 2024:

  • 19 published deliverables, including white papers, blogs, videos, FAQs, surveys and posters!

  • 17 new projects started in 2024.

  • We will start 2025 with 42 Working Group projects and many more in the pipeline.

Published

We have four more published deliverables. The published deliverables this quarter are:

Data Visualisation & Open Source Technology

Comparing Analysis Method Implementations in Software (CAMIS)


Optimizing the Use of Data Standards

Best Practices in Data Standards Implementation Governance

  • The Best Practices in Data Standards Implementation Governance project within the Optimizing the Use of Data Standards Working Group has published a new white paper. This white paper presents the results of the survey along with feedback from informal discussions at PHUSE’s Computational Science Symposium (CSS) sessions in 2022 and 2023. The data and observations shared are intended to inform industry and identify further projects for exploration while also encouraging industry collaboration for areas which are found to be the most challenging.

SDTM ADaM Implementation FAQ


Safety Analytics 

AE Groupings in Safety (AEGiS)

  • The AE Groupings in Safety (AEGiS) project within the Safety Analytics Working Group has published a new white paper. This white paper outlines why using standard AE groupings for queries is key to understanding a drug’s safety profile, discusses assumptions underlying the use of standard queries for estimation and outlines the benefits of standard queries when available. When standard queries are not available, but detailed analysis of a specific medical condition is needed, this document recommends a process to develop and maintain a custom query that can be replicated by regulatory authorities. 

Treatment Emergent Definitions Recommendations

Under Review 

  • No labels